Magellan Health Cmn (MGLN) 55.75 $MGLN Magellan
Post# of 273257

Magellan Health Opens Toll-Free Number to Assist Individuals after Flooding in Louisiana
BusinessWire - Wed Aug 17, 10:40AM CDT
Magellan Health, Inc. (NASDAQ: MGLN) today announced that in response to the flooding in parts of Louisiana, it has set up a 24-hour toll-free hotline for individuals to access, regardless of whether or not they are Magellan members.
MGLN: 55.75 (+0.63)
Magellan Health Collaborates with Bayer to Educate Members and Clinicians about Availability of Long-Acting Reversible Contraceptives
BusinessWire - Tue Aug 16, 9:13AM CDT
Magellan Health, Inc. (NASDAQ: MGLN) announced today that it has collaborated with Bayer to launch an education initiative designed to focus on women's health and reduce the rate of unintended pregnancies through the appropriate utilization of long-acting reversible contraceptives (LARC). Magellan Healthcare has launched an outreach campaign to improve education about and access to the full range of contraceptive methods for Magellan Complete Care of Florida members. In addition, in collaboration with Bayer, Magellan Rx Management, which provides pharmacy benefit management services for Magellan Complete Care of Florida, is utilizing advanced analytics to conduct intensified physician and member outreach and education to improve contraceptive utilization, including LARC therapy.
MGLN: 55.75 (+0.63)
Magellan Health Reports Second Quarter 2016 Financial Results
BusinessWire - Fri Jul 29, 5:30AM CDT
Magellan Health, Inc. (NASDAQ: MGLN) today reported financial results for the second quarter of 2016, as summarized below. For the quarter ended June 30, 2016, the company reported net revenue of $1.16 billion, segment profit of $56.9 million, and net income of $4.0 million, or $0.16 per diluted common share. In addition, the company reported adjusted net income of $14.4 million and adjusted earnings per share of $0.58. As of June 30, 2016, the company had unrestricted cash and investments of $236.3 million.
MGLN: 55.75 (+0.63)
Aetna (AET) and Units Receive Rating Action from A.M. Best
Zacks Equity Research - Zacks Investment Research - Fri Jun 24, 7:41AM CDT
Aetna Inc. (AET) and its affiliates recently received rating actions from A.M. Best.
AHS: 36.25 (+0.57), AET: 116.73 (+0.57), MGLN: 55.75 (+0.63), HUM: 177.33 (+0.80)
Nobilis Health (HLTH) in Focus: Stock Up 12.4% in Session
Zacks Equity Research - Zacks Investment Research - Wed Jun 22, 7:35AM CDT
Nobilis Health Corp. (HLTH) was a big mover last session, as the company saw its shares surge over 12% on the day.
HLTH: 3.74 (+0.14), MGLN: 55.75 (+0.63)
5 Medical Stocks with Incredibly Low PEG Ratios
Zacks Equity Research - Zacks Investment Research - Tue Jun 21, 10:08AM CDT
Medical is attractive for value investors due to its resiliency during volatile phases on the back of strong fundamentals of the constituent companies.
PMC: 25.95 (+0.76), ESRX: 72.54 (+0.32), AIRM: 35.79 (+0.90), PRAH: 50.38 (-0.18), MGLN: 55.75 (+0.63)
The Zacks Analyst Blog Highlights: Dean Foods, Dave & Buster's Entertainment, Magellan Health, Sanmina and Tallgrass Energy GP
Zacks Equity Research - Zacks Investment Research - Tue Jun 21, 8:30AM CDT
The Zacks Analyst Blog Highlights: Dean Foods, Dave & Buster's Entertainment, Magellan Health, Sanmina and Tallgrass Energy GP
PLAY: 46.60 (+0.36), DF: 17.25 (+0.20), TEGP: 23.26 (-0.11), SANM: 26.80 (+0.08), MGLN: 55.75 (+0.63)
5 Stocks to Combat Brexit Fears
Swarup Gupta - Zacks Investment Research - Mon Jun 20, 10:11AM CDT
EU and U.S. companies with significant investments in Europe are bracing themselves for a Brexit.
PLAY: 46.60 (+0.36), DF: 17.25 (+0.20), TEGP: 23.26 (-0.11), SANM: 26.80 (+0.08), MGLN: 55.75 (+0.63)
5 Best Low-Beta Stocks to Buy as Volatility Hits a 3-Month High
Zacks Equity Research - Zacks Investment Research - Mon Jun 13, 9:20AM CDT
A measure of expected volatility soared to its highest level in three months, the latest sign of increasing fears among investors.
PMC: 25.95 (+0.76), WPT: 15.42 (-0.05), PLAY: 46.60 (+0.36), DF: 17.25 (+0.20), MGLN: 55.75 (+0.63)
Magellan Health to Present at Barclays Select Series Pharmacy Benefit Management & Drug Pricing Symposium
BusinessWire - Tue Jun 07, 11:04AM CDT
Magellan Health, Inc. (NASDAQ: MGLN) announced today that Todd Lord, vice president of clinical strategy at Magellan Rx Management, the company's pharmacy benefit management division, will participate in two panel discussions at the Barclays Select Series Pharmacy Benefit Management and Drug Pricing Symposium in New York on Wednesday, June 15, 2016 from 11:15 a.m.-12:15 p.m. Eastern. The panels will cover the following topics: Value-based Pricing Initiatives and Formulary Innovation-What to Watch for 1/1/2017.
MGLN: 55.75 (+0.63)
Magellan Health and Employees Raise Nearly $27,000 for Annual St. Louis American Heart Walk
BusinessWire - Fri May 20, 10:00AM CDT
Magellan Health (NASDAQ: MGLN) announced today that local St. Louis-based employees have raised $16,963 for the 2016 American Heart Walk, in addition to a $10,000 corporate sponsorship from Magellan Health.
MGLN: 55.75 (+0.63)
Magellan of Virginia and Astyra Selected to Receive Metropolitan Business League's Trailblazer Partnership Award
BusinessWire - Fri May 20, 9:02AM CDT
Magellan of Virginia, a subsidiary of Magellan Health, Inc. (NASDAQ: MGLN), and Astyra Corporation were recently selected to receive the Metropolitan Business League's (MBL) Trailblazer Partnership Award for their work together. Astyra is a local Small, Women or Minority-owned (SWaM) business that specializes in providing staffing, outsourcing and technology capabilities to other companies. The Trailblazer Partnership Award recognizes a small business and its larger partner that formed a successful teaming relationship and/or joint venture that resulted in the award of a new contract or an ongoing relationship. Magellan works with Astyra to help staff customer service positions in Magellan's member call center.
MGLN: 55.75 (+0.63)
Will Humana (HUM) Grow In Spite of Segmental Weakness?
Zacks Equity Research - Zacks Investment Research - Thu May 19, 9:09AM CDT
On May 18, 2016, we issued an updated research report on Humana Inc. (HUM).
UNH: 136.61 (+0.87), AET: 116.73 (+0.57), MGLN: 55.75 (+0.63), HUM: 177.33 (+0.80)
Can Magellan Health (MGLN) Keep the Earnings Streak Alive This Quarter?
Zacks Equity Research - Zacks Investment Research - Thu May 19, 7:47AM CDT
Magellan Health (MGLN) boasts a favorable Zacks Rank and a positive Earnings ESP, which is a great sign of a coming earnings beat.
MGLN: 55.75 (+0.63)
Magellan Health to Expand Experience in Special Population Management with the Military and Veterans through Acquisition of Armed Forces Services Corporation
BusinessWire - Mon May 16, 5:30AM CDT
Magellan Health, Inc. (NASDAQ:MGLN), a leader in complex care and special population management, today announced that it has entered into an agreement to acquire Armed Forces Services Corporation (AFSC), a company with extensive experience providing and managing behavioral health and specialty services to various agencies of the federal government, including all five branches of the U.S. Armed Forces. This acquisition will enhance Magellan's existing footprint in special population management within the military and veteran communities, as well as other federal agencies. Headquartered in Arlington, Va., AFSC holds approximately 60 contracts with the federal government, and has 1,800 employees and subcontractors, with operations in all 50 states, three territories and eight countries. In 2015, AFSC had net revenues of approximately $135 million, with segment profit of approximately $16.5 million.
MGLN: 55.75 (+0.63)
Magellan Health Reports First Quarter 2016 Financial Results
BusinessWire - Thu May 05, 5:30AM CDT
Magellan Health, Inc. (NASDAQ: MGLN) today reported financial results for the first quarter of 2016, as summarized below. For the quarter ended March 31, 2016, the company reported net revenue of $1.12 billion, segment profit of $59.9 million, and net income of $13.2 million, or $0.54 per diluted common share. In addition, the company reported adjusted net income of $19.4 million and adjusted earnings per share of $0.79. As of March 31, 2016, the company had unrestricted cash and investments of $146.9 million.
MGLN: 55.75 (+0.63)
Magellan Rx Management's Site of Service Program Saves Two Regional Health Plans a Total of More Than $1 Million Over Six Months
BusinessWire - Fri Apr 29, 9:00AM CDT
Magellan Rx Management, the pharmacy benefit management (PBM) division of Magellan Health, Inc. (NASDAQ: MGLN), today announced that its clinical site of service program has delivered a total of more than $1 million dollars in savings in the first six months for two regional health plans, while generating positive feedback from patients.
MGLN: 55.75 (+0.63)
Magellan Health and Click Therapeutics Launch Fully Digital, Integrated and Comprehensive Smoking Cessation Program
BusinessWire - Wed Apr 20, 10:13AM CDT
Magellan Health, Inc. (NASDAQ: MGLN), a leader in the fastest growing, most complex areas of health, and Click Therapeutics, Inc., a leader in Digital Therapeutics(TM) solutions, today announced the launch of a unique fully digital, integrated and comprehensive smoking cessation program. The companies have leveraged Magellan's clinical coaching and pharmacy benefit management (PBM) capabilities with Click's technology and machine learning platform, including the mobile application, CLICKOTINE(R), to create this all-in-one solution. The full program, including access to a real-time data analytics portal, will be available to Magellan's employer, managed care and government customers. A study published in 2013 reviewed the medical and non-medical costs related to employing a smoker in the United States, and calculated an annual excess cost of more than $5,800 per employee that smokes.
MGLN: 55.75 (+0.63)
Magellan Rx Management Selected as a Preferred Provider for Mercer Rx Options
BusinessWire - Fri Apr 08, 10:18AM CDT
Magellan Rx Management, the pharmacy benefit management (PBM) division of Magellan Health, Inc. (NASDAQ: MGLN), announced today that it has been selected as a preferred provider in Mercer's Rx Options, a pharmacy collective program for plan sponsors with 50 to 1,500 employees. Rx Options enables plan sponsors to select preferred PBMs to provide a full suite of plan management and clinical programs, account management and comprehensive pharmacy solutions.
MGLN: 55.75 (+0.63)
IPG Board Names Vince Coppola as President and CEO
BusinessWire - Wed Mar 30, 9:30AM CDT
IPG, the recognized industry-leading provider of Surgical and Implant Cost Management solutions today announced that its Board of Directors named Vince Coppola as the company's President and Chief Executive Officer, effective March 31. As President and CEO, Vince will look to advance the company's growth and evolution, while further building out its customer base and product portfolio.
MGLN: 55.75 (+0.63)

